Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Haleon plc
HLN
$9.22
Name : Haleon plc
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $40,546,099,200.00
EPSttm : 0.49
finviz dynamic chart for HLN
Haleon plc
$9.22
0.11%
$0.01
HLN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.3

Margin Of Safety %

9

Put/Call OI Ratio

0.03

EPS Next Q Diff

EPS Last/This Y

0.06

EPS This/Next Y

0.05

Price

9.22

Target Price

11.37

Analyst Recom

2.12

Performance Q

1.49

Upside

16.9%

Beta

0.12

Ticker: HLN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-12HLN9.810.360.004387
2026-08-13HLN9.810.360.004401
2026-08-14HLN9.70.300.005098
2026-08-17HLN9.590.280.005296
2026-08-18HLN9.730.260.335575
2026-08-19HLN9.880.260.035581
2026-08-20HLN9.870.260.015578
2026-08-21HLN10.010.250.285738
2026-08-24HLN10.180.060.054316
2026-08-25HLN10.190.060.014373
2026-08-26HLN10.180.060.004464
2026-08-27HLN10.050.060.024574
2026-08-28HLN10.110.060.014601
2026-08-31HLN10.050.060.004703
2026-09-02HLN9.930.060.004820
2026-09-03HLN9.860.060.154867
2026-09-04HLN9.610.060.004986
2026-09-08HLN9.250.050.025464
2026-09-09HLN9.220.040.005720
2026-09-10HLN9.220.030.005815
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-13HLN9.80- -218.90.57
2026-08-14HLN9.70- -219.30.57
2026-08-17HLN9.59- -234.30.57
2026-08-18HLN9.73- -159.60.57
2026-08-19HLN9.88- -120.20.57
2026-08-20HLN9.87- -163.20.57
2026-08-21HLN10.02- -155.20.57
2026-08-24HLN10.18- -135.70.57
2026-08-25HLN10.19- -180.30.57
2026-08-26HLN10.19- -209.00.57
2026-08-27HLN10.04- -271.00.57
2026-08-28HLN10.10- -230.60.57
2026-08-31HLN10.05- -234.20.57
2026-09-01HLN10.07- -229.30.57
2026-09-02HLN9.92- 50.70.57
2026-09-03HLN9.83- 54.80.57
2026-09-04HLN9.61- 7.30.57
2026-09-08HLN9.26- -20.80.57
2026-09-09HLN9.22- 90.20.57
2026-09-10HLN9.22- 109.10.57
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-12HLN022.290.41
2026-08-13HLN022.290.41
2026-08-14HLN022.290.41
2026-08-17HLN021.340.41
2026-08-18HLN021.340.41
2026-08-19HLN021.340.41
2026-08-20HLN021.340.41
2026-08-21HLN021.340.41
2026-08-24HLN0-0.740.41
2026-08-25HLN0-0.740.41
2026-08-26HLN0-0.740.30
2026-08-27HLN0-0.740.30
2026-08-28HLN0-0.740.30
2026-08-31HLN0-0.430.30
2026-09-01HLN0-0.430.30
2026-09-02HLN0-0.430.30
2026-09-03HLN0-0.430.30
2026-09-04HLN0-0.430.30
2026-09-08HLN0-0.440.30
2026-09-09HLN0-0.440.30
2026-09-10HLN0-0.440.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.44

Beta

0.12

Average Sales Estimate Current Quarter

2931

Average Sales Estimate Next Quarter

2837

Fair Value

10.04

Quality Score

85

Growth Score

71

Sentiment Score

55

Actual DrawDown %

19.3

Max Drawdown 5-Year %

Target Price

11.37

P/E

18.95

Forward P/E

14.91

PEG

1.54

P/S

2.71

P/B

1.86

P/Free Cash Flow

14.73

EPS

0.49

Average EPS Est. Cur. Y​

0.57

EPS Next Y. (Est.)

0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.55

Relative Volume

1.56

Return on Equity vs Sector %

-16

Return on Equity vs Industry %

3.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

109.1
HLN Healthcare
$9.22
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
17/25
Volume
3/15
Valuation
20/20
TP/AR
1/10
Options
7/10
RSI
29.9
Range 1M
5.8%
Sup Dist
0.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
47 /100
WEAK
Momentum
14/25
Growth
15/30
Estimates
6/20
Inst/Vol
4/15
Options
8/10
EPS Yr
11.6%
EPS NY
8.9%
52W%
20.7%
💎
Long-Term Value
Quality companies, undervalued
44 /100
WEAK
🟢 BUY +31.3% upside
Quality
13/30
Valuation
11/30
Growth
13/25
Stability
3/10
LT Trend
4/5
Upside
+31.3%
Quality
85
MoS
9%
HLN — P/E HistoricalDrug Manufacturers - Specialty & Generic
Haleon plc
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 24535
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
HLN

Latest News

Caricamento notizie per HLN
stock quote shares HLN – Haleon plcHLN Stock Price stock today
news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025
marketwatch HLN – Haleon plcHLN yahoo finance google finance
stock history HLN – Haleon plcHLN invest stock market
stock prices HLN premarket after hours
ticker HLN fair value insiders trading